SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.
SmithRx has raised $60.0M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
SmithRx's investors include Founders Fund, BoxGroup, Venrock, Four Cities Capital, Precursor Ventures.
SmithRx is headquartered in San Francisco, United States.
SmithRx is reinventing PBMs with modern technology, client alignment, and 100% transparency.
SmithRx is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SmithRx — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/smithrx. Accessed July 19, 2026.
VCBacked. (2024). SmithRx — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/smithrx
{{cite web |title=SmithRx — Funding & Investors |url=https://www.vcbacked.co/company/smithrx |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated